Clinical Trials Browser

Phase 2 × Withdrawn × futuximab × Clear all

NCT02965417 2017-02-01

Sym004 in Metastatic Colorectal Cancer and ECD-EGFR Patients

Phase 2 Withdrawn

Gastrointestinal

Colorectal Neoplasms